Occipital Fibrosing Alopecia in a Young Male: A Case Report.
Frontal fibrosing alopecia
Lichen planopilaris
Occipital alopecia
Occipital fibrosing alopecia
Primary scarring alopecia
Scarring alopecia
Journal
Skin appendage disorders
ISSN: 2296-9195
Titre abrégé: Skin Appendage Disord
Pays: Switzerland
ID NLM: 101670617
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
22
07
2020
accepted:
24
09
2020
entrez:
22
2
2021
pubmed:
23
2
2021
medline:
23
2
2021
Statut:
ppublish
Résumé
Lichen planopilaris (LPP) is a primary lymphocytic cicatricial alopecia with 3 recognized clinical variants. Lately, LPP clinical spectrum has expanded with new and overlapping clinical variants. First considered as a subtype of LPP affecting postmenopausal women, the increasing worldwide incidence of FFA including atypical lesions in young female and male suggests a different pathomechanism for this disease. Although LPP-spectrum disorders may share similar histopathological findings, clinical features and prognosis are different. A 26-year-old Caucasian male presented with occipital scarring alopecia and pruritus for the last 6 months. The patient had been treated for an associated androgenetic alopecia and superficial recurrent scalp folliculitis over the vertex scalp for the last 5 years. Trichoscopy of the occipital scalp showed mild diffuse erythema, moderate peripilar scaling, and absence of follicular openings, suggestive of a scarring process. The patient underwent an occipital scalp biopsy that confirmed the diagnosis of a LPP-spectrum disorder. Both LPP and FFA mostly affect the anterior-mid scalp of females. However, recent reports on FFA also in premenopausal women and men should make physicians aware of atypical features of this disease and unusual clinical presentation.
Identifiants
pubmed: 33614725
doi: 10.1159/000512034
pii: sad-0007-0071
pmc: PMC7879329
doi:
Types de publication
Case Reports
Langues
eng
Pagination
71-74Informations de copyright
Copyright © 2020 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Actas Dermosifiliogr. 2016 Dec;107(10):836-844
pubmed: 27499250
Exp Dermatol. 2020 Mar;29(3):278-281
pubmed: 30403306
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e405-e407
pubmed: 32153060
J Am Acad Dermatol. 2007 Aug;57(2 Suppl):S15-8
pubmed: 17637362
J Drugs Dermatol. 2012 Jun;11(6):753-8
pubmed: 22648224
J Dtsch Dermatol Ges. 2014 Mar;12(3):229-35, 229-36
pubmed: 24533855
Int J Trichology. 2015 Jul-Sep;7(3):119-22
pubmed: 26622155
Skin Appendage Disord. 2018 Jan;4(1):50-54
pubmed: 29457017
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e326-e329
pubmed: 32043632
Int J Womens Dermatol. 2015 Sep 16;1(3):140-149
pubmed: 28491978
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):e218-e220
pubmed: 29224248
J Dermatolog Treat. 2019 Sep;30(6):598-604
pubmed: 30411987
J Am Acad Dermatol. 2017 Oct;77(4):683-690.e2
pubmed: 28716436
J Invest Dermatol. 2009 May;129(5):1243-57
pubmed: 19052558
Arch Dermatol. 1994 Jun;130(6):770-4
pubmed: 8002649
J Am Acad Dermatol. 2005 Apr;52(4):637-43
pubmed: 15793514